MPH HEALTH CARE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.4 EUR | 0.00% |
|
-5.93% | +52.55% |
| Sales 2024 * | 37.22M 40.59M | Sales 2025 * | 38.82M 42.33M | Capitalization | 106M 116M |
|---|---|---|---|---|---|
| Net income 2024 * | 33M 35.99M | Net income 2025 * | 35M 38.17M | EV / Sales 2024 * | 2.85 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.74 x |
| P/E ratio 2024 * |
31.8
x | P/E ratio 2025 * |
30.2
x | Employees | 2 |
| Yield 2024 * |
4.84% | Yield 2025 * |
4.84% | Free-Float | 40% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -5.93% | ||
| Current month | -5.22% | ||
| 1 month | -23.49% | ||
| 3 months | +23.30% | ||
| 6 months | +56.31% | ||
| Current year | +52.55% |
1 week
24.40
27.40
1 month
24.4033.00
Current year
15.6035.60
1 year
13.8535.60
3 years
9.2035.60
5 years
9.2042.50
10 years
9.2054.50
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-12 | 25.4 | 0.00% | 1,961 |
| 24-07-11 | 25.4 | -0.78% | 932 |
| 24-07-10 | 25.6 | -2.29% | 1,218 |
| 24-07-09 | 26.2 | +1.55% | 1,754 |
| 24-07-08 | 25.8 | -4.44% | 8,436 |
Delayed Quote Xetra, July 12, 2024 at 11:36 am EDT
More quotes
MPH Health Care AG, formarly MPH Mittelstaendische Pharma Holding AG, is a Germany-based pharmaceuticals and investment company. The Company focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The Company's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
24.8
EUR
Average target price
113
EUR
Spread / Average Target
+355.65%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +25.24% | 45.32B | |
| +34.85% | 24.51B | |
| +29.56% | 16.85B | |
| +21.32% | 14.62B | |
| +70.51% | 14.16B | |
| -0.05% | 6.79B | |
| +15.74% | 5.82B | |
| -8.87% | 5.73B | |
| +10.29% | 4.93B |
- Stock Market
- Equities
- 93M1 Stock
- 93M1 Stock
